Gary Loeb
CIK 1561733 · EVP & Chief Legal and Complian · last filed 2026-10-13
Gary Loeb is an EVP & Chief Legal and Complian who has filed 45 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for ISRG, was dated Oct 13, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ISRG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUNNYVALE, CA 94086
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ISRG | EVP & Chief Legal and Complian | 6,636 | $427.61 | $2.84M | -$2.27M | 22 | 2026-10-13 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | EVP, General Counsel & Sec. | 83,238 | $0.18 | $14.8K | -$230.0K | 5 | 2021-03-25 |
| Achaogen, Inc. (AKAO) Delisted | See Remarks | 239,673 | — | — | -$35.2K | 9 | 2019-02-25 |
| AMYRIS, INC. (AMRS) Delisted | SVP, Gen'l Counsel & Secretary | 9,226 | $0.05 | $461 | $0 | 3 | 2013-06-25 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-13 | ISRG | Mixed | +1,316 | -$549.5K | EDGAR |
| 2026-08-10 | ISRG | Notice (144) | −400 | -$151.5K | EDGAR |
| 2026-08-10 | ISRG | Sell (S) | −400 | -$151.6K | EDGAR |
| 2026-06-10 | ISRG | Notice (144) | −400 | -$170.6K | EDGAR |
| 2026-06-10 | ISRG | Sell (S) | −400 | -$169.7K | EDGAR |
| 2026-05-11 | ISRG | Notice (144) | −400 | -$180.0K | EDGAR |
| 2026-05-11 | ISRG | Sell (S) | −400 | -$178.8K | EDGAR |
| 2026-03-02 | ISRG | Mixed | +1,586 | -$786.5K | EDGAR |
| 2026-02-27 | ISRG | Mixed | +1,230 | -$613.5K | EDGAR |
| 2026-02-10 | ISRG | Mixed | +143 | -$84.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.